Nucleotide-binding oligomerization domain-2 (NOD2)-knockdown in mice increases cardiac hypertrophy and fibrosis by upregulating multiple pathways, including the TLR4/NF-κB, TLR4/MAPK, and TGF-β/Smad pathways (93). The gene discussed is NFKB1; the disease is cardiac hypertrophy.